The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy free access to a wealth of online resources, including 5,000 subscription and open access e-journals, 2,000 e-books and 5 key medical databases, to support your clinical decision-making and research.
- Date and time Thu 21 Apr 2022 from 2:00pm to 5:30pm
- Location Royal Society of Medicine
- Organised by Dermatology
This event will help you understand the diagnosis and management of rarer and more unusual dermatology conditions and unusual presentations of common dermatological problems.
The annual Research Prize Presentation promotes awareness of new and exciting dermatological research amongst our trainees.
Event topics include:
- The diagnosis and management of rarer and more unusual dermatology conditions and unusual presentations of common dermatological problems
- Recent progress in diagnostics and management of dermatological conditions
- The impact of skin disorders on individuals and the importance of a holistic approach to management
- New research in dermatology
Can't join us in-person at the RSM? You can also book to watch this event via live stream by clicking here.
You can only attend this meeting if you hold a Consultant or training post in dermatology. You must bring ID with you to show this. Exceptions are made for those who are members of the Section (by completing an additional application form) who have made significant contributions to dermatology and are of good standing in dermatology and the profession.
This event will be recorded*, all registered delegates will be able to access the recording for 60 days after on Zoom. The link will be sent 24 hours after the event takes place.
CPD learning applied.
*Subject to speakers consent
The Dermatology Section would like to thank our Annual Sponsors AbbVie, Almirall, Eucerin, Janssen-Cilag, La Roche-Posay & Cerave, Lilly UK, Sanofi Genzyme and UCB Ltd for their valued support of the 2021 to 2022 Academic Programme. We would also like to thank our sponsors Amgen, LEO Pharma and Pierre Fabre for their support of this meeting.
Please note that none of the companies listed has had any influence or involvement over the agenda, content or organisation of the meetings.
View the programme
Disclaimer: All views expressed at this event are of the speakers themselves and not of the RSM.
This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.